The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...
Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
The Food and Drug Administration told CBS News it cannot comment ... main ingredient semaglutide. FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, ...
European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...
As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...
After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as ...
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...